ICO Hospital Durans i Reynals Report issue

Academic/Hospital Phase 2
Founded: Barcelona Spain (1996)

Organization Overview

First Clinical Trial
2009
NCT01015248
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

ICO Hospitalet | ICO- Hospitalet

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 2)

Melanoma (Phase 2)

Neuroendocrine Tumors (Phase 2)

Penile Neoplasms (Phase 2)

Uveal Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 7